....
The complaint alleges that, throughout the Relevant Period, the defendants deliberately engaged in repeated spoofing that interfered with the natural forces of supply and demand, and drove NWBO’s share price downward repeatedly over the course of the Relevant Period. The defendants are accused of violating Section 10(b), Rule 10b-5 and Section 9(a)(2) of the Securities Exchange Act of 1934, and of fraud under New York state common law.
NWBO is a clinical stage biotechnology company focused on the development of personalized cancer vaccines. Despite the string of encouraging news about its lead product, NWBO’s share price has not followed suit. Quite the opposite actually. The plaintiff alleges that because of Defendants’ spoofing, NWBO’s share price has dropped....
YOU CAN'T MAKE THIS STUFF UP
(20min delay)